SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study

Laura N. Rossiera Intesto, Gastroenterology and Crohn-Colitis Center, Fribourg and Berne, Switzerland;b Faculty of Medicine, University of Fribourg, Switzerland

Natalie P. Décosterda Intesto, Gastroenterology and Crohn-Colitis Center, Fribourg and Berne, Switzerland

Christoph B. Mattera Intesto, Gastroenterology and Crohn-Colitis Center, Fribourg and Berne, Switzerland

Dominic A. Staudenmanna Intesto, Gastroenterology and Crohn-Colitis Center, Fribourg and Berne, Switzerland;b Faculty of Medicine, University of Fribourg, Switzerland

André Moserc CTU Bern, University of Bern, Switzerland

Bernhard Eggerb Faculty of Medicine, University of Fribourg, Switzerland;d Department of Surgery, Cantonal Hospital Fribourg

Frank W. Seibolda Intesto, Gastroenterology and Crohn-Colitis Center, Fribourg and Berne, Switzerland;b Faculty of Medicine, University of Fribourg, SwitzerlandCorrespondence[email protected]

https://orcid.org/0009-0005-8219-2193

show all

SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date